TapewireFind a company

person · Reporting owner

Khayal Tamer I

Disclosed activity across 1 company

Tapewire entity
82348
SEC CIK
0001430462

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
TransMedics Group, Inc.TMDX · Entity 4261Chief Commercial OfficerMarch 03, 2025March 05, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

TransMedics Group, Inc.

Report date March 03, 2025 · Filed March 05, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect36,042 Reported balance After 2025-03-03 transaction · row 1
1 source row

Row 1 · 2025-03-03 · Sale · Disposed 2,407 · Balance 36,042

F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.

Filing footnotes · ownership attribution and instrument terms

F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 01, 2024 Filed Aug 5, 2024 18:08 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 116 $161.99 $18,790.84
Disclosure

SEC source: 0000950170-24-091017 · ownership.xml · nonDerivative · entry 14

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,973

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F12 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $161.67 to $162.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 18:08 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 126 $161.09 $20,297.34
Disclosure

SEC source: 0000950170-24-091017 · ownership.xml · nonDerivative · entry 13

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,089

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F11 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $160.63 to $161.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 18:08 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 329 $159.86 $52,593.94
Disclosure

SEC source: 0000950170-24-091017 · ownership.xml · nonDerivative · entry 12

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,215

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F10 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $159.47 to $160.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 18:08 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 240 $158.88 $38,131.20
Disclosure

SEC source: 0000950170-24-091017 · ownership.xml · nonDerivative · entry 11

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,544

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F9 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $158.39 to $159.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 18:08 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 252 $157.83 $39,773.16
Disclosure

SEC source: 0000950170-24-091017 · ownership.xml · nonDerivative · entry 10

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,784

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F8 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $157.39 to $158.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 18:08 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 124 $157.00 $19,468.00
Disclosure

SEC source: 0000950170-24-091017 · ownership.xml · nonDerivative · entry 9

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,036

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $156.29 to $157.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 18:08 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 380 $155.69 $59,162.20
Disclosure

SEC source: 0000950170-24-091017 · ownership.xml · nonDerivative · entry 8

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,160

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $155.28 to $156.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 18:08 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 510 $154.86 $78,978.60
Disclosure

SEC source: 0000950170-24-091017 · ownership.xml · nonDerivative · entry 7

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,540

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $154.27 to $155.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 18:08 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 483 $153.81 $74,290.23
Disclosure

SEC source: 0000950170-24-091017 · ownership.xml · nonDerivative · entry 6

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,050

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $153.24 to $154.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 18:08 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 154 $152.71 $23,517.34
Disclosure

SEC source: 0000950170-24-091017 · ownership.xml · nonDerivative · entry 5

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,533

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $152.20 to $153.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 18:08 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 114 $151.80 $17,305.20
Disclosure

SEC source: 0000950170-24-091017 · ownership.xml · nonDerivative · entry 4

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,687

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $151.19 to $152.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 18:08 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 1,083 $13.28 $14,382.24
Disclosure

SEC source: 0000950170-24-091017 · ownership.xml · nonDerivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,801

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 18:08 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 417 $66.10 $27,563.70
Disclosure

SEC source: 0000950170-24-091017 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,718

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 18:08 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 1,458 $38.46 $56,074.68
Disclosure

SEC source: 0000950170-24-091017 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,301

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 1,083 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0000950170-24-081567 · ownership.xml · derivative · entry 11

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,667

Underlying: Common Stock · 1,083 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F9 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 417 $0.00 Strike: $66.10 $0.00
Disclosure

SEC source: 0000950170-24-081567 · ownership.xml · derivative · entry 10

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,349

Underlying: Common Stock · 417 shares

Expires 2033-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F8 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 20, 2027.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 1,458 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000950170-24-081567 · ownership.xml · derivative · entry 9

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,667

Underlying: Common Stock · 1,458 shares

Expires 2031-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F7 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 160 $153.48 $24,556.80
Disclosure

SEC source: 0000950170-24-081567 · ownership.xml · nonDerivative · entry 8

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,843

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $153.04 to $153.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 582 $152.53 $88,772.46
Disclosure

SEC source: 0000950170-24-081567 · ownership.xml · nonDerivative · entry 7

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,003

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $152.00 to $152.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 1,106 $151.33 $167,370.98
Disclosure

SEC source: 0000950170-24-081567 · ownership.xml · nonDerivative · entry 6

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,585

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $151.00 to $151.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 1,000 $150.70 $150,700.00
Disclosure

SEC source: 0000950170-24-081567 · ownership.xml · nonDerivative · entry 5

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,691

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $150.00 to $150.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 110 $149.57 $16,452.70
Disclosure

SEC source: 0000950170-24-081567 · ownership.xml · nonDerivative · entry 4

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,691

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $149.00 to $149.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 1,083 $13.28 $14,382.24
Disclosure

SEC source: 0000950170-24-081567 · ownership.xml · nonDerivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,801

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 417 $66.10 $27,563.70
Disclosure

SEC source: 0000950170-24-081567 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,718

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 1,458 $38.46 $56,074.68
Disclosure

SEC source: 0000950170-24-081567 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,301

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 17:11 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 1,084 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0000950170-24-069423 · ownership.xml · derivative · entry 13

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,750

Underlying: Common Stock · 1,084 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F11 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 17:11 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 417 $0.00 Strike: $66.10 $0.00
Disclosure

SEC source: 0000950170-24-069423 · ownership.xml · derivative · entry 12

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,766

Underlying: Common Stock · 417 shares

Expires 2033-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F10 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 20, 2027.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 17:11 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 1,459 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000950170-24-069423 · ownership.xml · derivative · entry 11

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,125

Underlying: Common Stock · 1,459 shares

Expires 2031-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F9 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 17:11 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 457 $135.97 $62,138.29
Disclosure

SEC source: 0000950170-24-069423 · ownership.xml · nonDerivative · entry 10

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,843

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F8 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $135.37 to $136.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 17:11 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 152 $134.66 $20,468.32
Disclosure

SEC source: 0000950170-24-069423 · ownership.xml · nonDerivative · entry 9

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,300

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $134.33 to $135.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 17:11 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 567 $133.67 $75,790.89
Disclosure

SEC source: 0000950170-24-069423 · ownership.xml · nonDerivative · entry 8

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,452

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $133.31 to $134.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 17:11 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 921 $132.71 $122,225.91
Disclosure

SEC source: 0000950170-24-069423 · ownership.xml · nonDerivative · entry 7

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,019

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $132.315 to $133.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 17:11 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 539 $131.87 $71,077.93
Disclosure

SEC source: 0000950170-24-069423 · ownership.xml · nonDerivative · entry 6

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,940

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $131.30 to $132.295, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 17:11 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 219 $130.79 $28,643.01
Disclosure

SEC source: 0000950170-24-069423 · ownership.xml · nonDerivative · entry 5

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,479

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $130.315 to $131.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 17:11 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 105 $129.92 $13,641.60
Disclosure

SEC source: 0000950170-24-069423 · ownership.xml · nonDerivative · entry 4

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,698

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $129.30 to $130.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 17:11 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 1,084 $13.28 $14,395.52
Disclosure

SEC source: 0000950170-24-069423 · ownership.xml · nonDerivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,803

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 17:11 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 417 $66.10 $27,563.70
Disclosure

SEC source: 0000950170-24-069423 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,719

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 17:11 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 1,459 $38.46 $56,113.14
Disclosure

SEC source: 0000950170-24-069423 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,302

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
May 06, 2024 Filed May 8, 2024 16:32 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 5,839 $0.00 Strike: $66.10 $0.00
Disclosure

SEC source: 0000950170-24-055795 · ownership.xml · derivative · entry 4

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,183

Underlying: Common Stock · 5,839 shares

Expires 2033-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027.

Read SEC document
May 06, 2024 Filed May 8, 2024 16:32 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 5,839 $130.07 $759,478.73
Disclosure

SEC source: 0000950170-24-055795 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,792

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $130.00 to $130.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 06, 2024 Filed May 8, 2024 16:32 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 5,839 $66.10 $385,957.90
Disclosure

SEC source: 0000950170-24-055795 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,631

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
May 01, 2024 Filed May 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 1,083 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0000950170-24-052962 · ownership.xml · derivative · entry 24

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,834

Underlying: Common Stock · 1,083 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F18 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.

Read SEC document
May 01, 2024 Filed May 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 1,458 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000950170-24-052962 · ownership.xml · derivative · entry 23

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,584

Underlying: Common Stock · 1,458 shares

Expires 2031-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F17 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
May 01, 2024 Filed May 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 45,326 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000950170-24-052962 · ownership.xml · derivative · entry 22

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,042

Underlying: Common Stock · 45,326 shares

Expires 2031-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F17 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
May 01, 2024 Filed May 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 7,388 $120.01 $886,633.88
Disclosure

SEC source: 0000950170-24-052962 · ownership.xml · nonDerivative · entry 20

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By the Khayal Family 2021 Irrevocable Trust

Disclosed balance after: 0

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F16 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $120.00 to $120.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 01, 2024 Filed May 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 500 $111.50 $55,750.00
Disclosure

SEC source: 0000950170-24-052962 · ownership.xml · nonDerivative · entry 19

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By the Khayal Family 2021 Irrevocable Trust

Disclosed balance after: 7,388

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F15 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $111.41 to $111.6375, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 01, 2024 Filed May 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 6,888 $110.06 $758,093.28
Disclosure

SEC source: 0000950170-24-052962 · ownership.xml · nonDerivative · entry 18

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By the Khayal Family 2021 Irrevocable Trust

Disclosed balance after: 7,888

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F14 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $110.00 to $110.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 01, 2024 Filed May 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 100 $123.66 $12,366.00
Disclosure

SEC source: 0000950170-24-052962 · ownership.xml · nonDerivative · entry 17

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,792

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F13 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $123.64 to $123.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 01, 2024 Filed May 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 17 $122.51 $2,082.67
Disclosure

SEC source: 0000950170-24-052962 · ownership.xml · nonDerivative · entry 16

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,892

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
May 01, 2024 Filed May 3, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 532 $121.74 $64,765.68
Disclosure

SEC source: 0000950170-24-052962 · ownership.xml · nonDerivative · entry 15

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,909

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F12 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $121.43 to $122.355, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.